Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis

Clin Neurol Neurosurg. 2012 Sep;114(7):1057-8. doi: 10.1016/j.clineuro.2012.02.001. Epub 2012 Mar 3.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Brain / pathology
  • Cidofovir
  • Cytosine / analogs & derivatives
  • Cytosine / therapeutic use
  • Female
  • Gait Disorders, Neurologic / etiology
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Leukoencephalopathy, Progressive Multifocal / complications
  • Leukoencephalopathy, Progressive Multifocal / pathology
  • Leukoencephalopathy, Progressive Multifocal / therapy*
  • Magnetic Resonance Imaging
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use
  • Mianserin / analogs & derivatives
  • Mianserin / therapeutic use
  • Middle Aged
  • Mirtazapine
  • Organophosphonates / therapeutic use
  • Prednisolone / adverse effects
  • Prednisolone / therapeutic use
  • Receptor, Serotonin, 5-HT2A / drug effects
  • Sarcoidosis / complications
  • Sarcoidosis / pathology
  • Sarcoidosis / therapy*
  • Serotonin Antagonists / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Immunosuppressive Agents
  • Organophosphonates
  • Receptor, Serotonin, 5-HT2A
  • Serotonin Antagonists
  • Mianserin
  • Cytosine
  • Prednisolone
  • Mirtazapine
  • Cidofovir
  • Methotrexate